A novel needle for subcutaneous injection of interferon beta-1a: effect on pain in volunteers and satisfaction in patients with multiple sclerosis
Open Access
- 10 October 2008
- journal article
- research article
- Published by Springer Nature in BMC Neurology
- Vol. 8 (1) , 38
- https://doi.org/10.1186/1471-2377-8-38
Abstract
To reduce injection pain and improve satisfaction, a thinner (29-gauge [29G]), sharper (5-bevel) needle than the 27G/3-bevel needle used previously to inject interferon (IFN) beta-1a, 44 or 22 mcg subcutaneously (sc) three times weekly (tiw), was developed for use in multiple sclerosis (MS).This publication has 7 references indexed in Scilit:
- Enhanced Benefit of Increasing Interferon Beta-1a Dose and Frequency in Relapsing Multiple SclerosisArchives of Neurology, 2005
- Improving needle-point sharpness in prefillable syringes.2003
- PRISMS-4: Long-term efficacy of interferon-β-1a in relapsing MSNeurology, 2001
- Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group.1998
- Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosisThe Lancet, 1998
- The Descriptor Differential Scale: applying psychophysical principles to clinical pain assessmentPain, 1988
- A validation model for verbal descriptor scaling of human clinical painPain, 1980